Pharmaceutical Raw Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2

Inkcazelo emfutshane:

I-Cabazitaxel yinto ekrwada yamayeza enokuthintela ukukhula kweeseli zomhlaza kwaye ibangele ukuba iiseli zomhlaza zife.Ichiza eligqityiweyo i-cabazitaxel lisetyenziselwa ukunyanga i-metastatic prostate cancer.I-Hande Bio ibonelela nge-Pharmaceutical Raw Anti-Cancer API Cabazitaxel Powder CAS 183133-96-2.Ukuze ufumane iinkcukacha ezithe vetshe, nceda uqhagamshelane nathi kwi-intanethi.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Ulwazi ngeMveliso

Igama:Cabazitaxel

Inombolo yeCAS:183133-96-2

Ifomula yemichiza:C45H57NO14

Iinkcukacha:99%

Umbala:umgubo omhlophe okanye omhlophe

Umthombo:ISemi-synthesized nge-10-DAB

Uhlobo:APIs

Umsebenzi

Ulingo lwezonyango lubonise ukuba i-cabazitaxel inokucutha amathumba, icothise ukukhula okanye ukusasazeka kwamathumba, kwaye ithomalalise iimpawu zomhlaza wedlala lesinyi.

Umthamo wemveliso yesandla

Umjikelo wemveliso:30-45 iintsuku.

Ibhetshi yemveliso:ibhetshi enye inokuvelisa malunga ne-15kg.

Umthamo wemveliso yesandla:kukho uluhlu lwempahla kwaye lunokuveliswa ngobuninzi.

Iinzuzo zemveliso yezandla

I-Hande, eyakhe isiseko sayo semveliso ye-GMP, iphumelele uphononongo lwemithetho nemimiselo ye-FDA, i-EDQM, i-GMP e-China, i-PMDA e-Japan, i-TGA e-Australia, eMzantsi Korea, e-Indiya, eTaiwan, e-China, Türkiye, Russia, SGS ,Dun & Bradley, etc.Ngexesha elifanayo, inkampani ixhotyiswe ngeqela lophando kunye neqela lophuhliso kwaye ifumene ngokulandelelana inani lepatent.Igumbi lokuvavanya i-QC, iqonda kakhulu uvavanyo lweprojekthi yemveliso.

Iinkonzo zethu

1.Iimveliso:Ukubonelela ngomgangatho ophezulu, izicatshulwa zezityalo ezisulungekileyo, imathiriyeli ekrwada yamayeza, kunye nabaphakathi bamayeza.

2.Iinkonzo zobugcisa:Izicatshulwa ezenziwe ngokwezifiso ezineenkcazo ezizodwa ngokweemfuno zabathengi.

Umzi-mveliso we-Hande

Yiba ngoyena mthengisi ubalaseleyo wezinto ezikrwada kunye namashishini anentembeko!

Wamkelekile ukuba uqhagamshelane nam ngokuthumela i-imeyile kumarketing@handebio.com


  • Ngaphambili:
  • Okulandelayo: